Prognostic Characteristics of Breast Cancer Among Postmenopausal Hormone Users in a Screened Population
- 1 December 2003
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (23), 4314-4321
- https://doi.org/10.1200/jco.2003.05.151
Abstract
Purpose: We determined the risk of breast cancer and tumor characteristics among current postmenopausal hormone therapy users compared with nonusers, by duration of use.Keywords
This publication has 42 references indexed in Scilit:
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Pathologic and Biological Prognostic Factors of Breast Cancers in Short- and Long-Term Hormone Replacement Therapy UsersAnnals of Surgical Oncology, 2002
- Progestin Effects on Long-Term Growth, Death, and Bcl-xL in Breast Cancer CellsBiochemical and Biophysical Research Communications, 2000
- Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancerInternational Journal of Cancer, 1998
- Hormone replacement therapy and biological aggressiveness of breast cancerThe Lancet, 1997
- Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database.American Journal of Roentgenology, 1997
- Prognostic characteristics in breast cancers after hormone replacement therapyBreast Cancer Research and Treatment, 1996
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)Cancer Causes & Control, 1994